• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Steve Jobs’ Son Launches $200M Fund to Fight Against Cancer

by Fred Pennic 08/01/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Steve Jobs’ Son Launches $200M VC Fund to Fight Against Cancer
 Reed Jobs of Yosemite

What You Should Know:

  • Reed Jobs – the son of Steve Jobs today announced the launch of his new venture capital (VC) investment fund, Yosemite, spun out from Emerson Collective Health with an oversubscribed $200M+ first close.
  • Yosemite aims to meaningfully accelerate the technology, treatments, and standard of care that have the power to improve the health and lives of cancer patients.
  • Composed of the Emerson Health team, Yosemite’s unique model provides no-strings-attached philanthropic grants to emerging researchers while investing in promising incubation and early-translation companies in therapeutics, diagnostics, and digital health.

Yosemite’s Global Network

Yosemite’s global network is designed to identify and fuel the most promising advances in treatment, technology, and standards of care. Strong relationships formed through grantmaking have often led academic researchers to return to the team with investment and company-creation opportunities. Yosemite brings an impressive track record of identifying emerging scientists and budding entrepreneurs on the cusp of scientific breakthroughs. Yosemite leaders have supported hundreds of researchers and invested in dozens of therapeutic and diagnostic companies across the U.S., Europe, and Israel to date.  

“We’re on a mission to lead the next chapter in the fight against cancer and forming our own standalone entity provides us the flexibility to best propel great ideas until they’re at scale,” said Reed Jobs of Yosemite. “We believe this first close demonstrates investor confidence in Yosemite’s strategy of building new companies, trust in our extensive grantee and institutional network, and value in our combined experience in shepherding new transformational cancer treatments.” 

Yosemite’s Limited Partners (LPs)

Yosemite’s Limited Partners include leading endowments, hospital systems and global family offices – such as The Rockefeller University, Memorial Sloan Kettering Cancer Center (MSK) and John Doerr. Emerson Collective will be a Limited Partner in Yosemite Fund I. Going forward, Yosemite will manage the Emerson Health legacy portfolio (ECI Health Funds) as an investment advisor.  

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |